Dabigatran etexilate


( Last Updated : March 18, 2013)
Generic Name:
Dabigatran etexilate
Project Status:
Complete
Therapeutic Area:
Atrial fibrillation prevention of stroke and systemic embolism
Manufacturer:
Boehringer Ingelheim (Canada) Ltd
Brand Name:
Pradaxa
Project Line:
Reimbursement Review
Project Number:
SF0320-000

Details


Submission Type:
Request For Advice
Indications:
Atrial fibrillation prevention of stroke and systemic embolism
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: